BENITEC BIOPHARMA INC. (BNTC) Free cash flow 2019–2026
BENITEC BIOPHARMA INC. (BNTC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$16.6MFY2026 · since FY2019: $4.4M → -$16.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$16.6M | +29.6% |
| FY2025 | -$23.6M | -20.5% |
| FY2024 | -$19.6M | -8.7% |
| FY2023 | -$18.0M | -13.2% |
| FY2022 | -$15.9M | -21.9% |
| FY2021 | -$13.1M | -71.1% |
| FY2020 | -$7.6M | -274.0% |
| FY2019 | $4.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BNTC financial trends
BNTC RevenueBNTC Net incomeBNTC Net marginBNTC Gross profitBNTC Gross marginBNTC Operating incomeBNTC Operating marginBNTC Operating cash flowBNTC Capital expendituresBNTC Return on equityBNTC Stock buybacksBNTC Dividends paidBNTC Total assetsBNTC Total liabilitiesBNTC Shareholders’ equityBNTC overview →